$31.47
0.943.08%
At Close: -
$31.47
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Castle Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Castle Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $0.31 | $-0.29 | 206.9 % |
Mar 2024 | 2024-05-02 | $-0.09 | $-0.33 | 72.7 % |
Dec 2023 | 2024-02-28 | $-0.10 | $-0.54 | 81.5 % |
Sep 2023 | 2023-11-02 | $-0.26 | $-0.76 | 65.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $87.00M | $69.08M | 25.9 % |
Mar 2024 | 2024-05-02 | $72.97M | $66.20M | 10.2 % |
Dec 2023 | 2024-02-28 | $66.12M | $56.28M | 17.5 % |
Sep 2023 | 2023-11-02 | $61.49M | $48.52M | 26.7 % |
Castle Biosciences (CSTL) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.
The Actual EPS was $0.31, which beat the estimate of $-0.29.
The Actual Revenue was $87M, which beat the estimate of $69.1M.
Browse earnings estimates, EPS, and revenue on all stocks.